SEC16A
Basic information
Region (hg38): 9:136440096-136483759
Previous symbols: [ "KIAA0310" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (336 variants)
- not_provided (39 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SEC16A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014866.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 19 | ||||
| missense | 310 | 32 | 349 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 0 | 0 | 311 | 45 | 13 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SEC16A | protein_coding | protein_coding | ENST00000313050 | 30 | 37593 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.360 | 0.640 | 124574 | 0 | 75 | 124649 | 0.000301 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.472 | 1458 | 1.41e+3 | 1.04 | 0.0000872 | 15157 |
| Missense in Polyphen | 434 | 473.1 | 0.91736 | 5336 | ||
| Synonymous | -3.06 | 701 | 605 | 1.16 | 0.0000448 | 4899 |
| Loss of Function | 7.06 | 22 | 97.0 | 0.227 | 0.00000479 | 1110 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000982 | 0.000953 |
| Ashkenazi Jewish | 0.000424 | 0.000398 |
| East Asian | 0.000343 | 0.000334 |
| Finnish | 0.000285 | 0.000278 |
| European (Non-Finnish) | 0.000263 | 0.000257 |
| Middle Eastern | 0.000343 | 0.000334 |
| South Asian | 0.000132 | 0.000131 |
| Other | 0.000335 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Defines endoplasmic reticulum exit sites (ERES) and is required for secretory cargo traffic from the endoplasmic reticulum to the Golgi apparatus. SAR1A-GTP-dependent assembly of SEC16A on the ER membrane forms an organized scaffold defining an ERES. Required for normal transitional endoplasmic reticulum (tER) organization. {ECO:0000269|PubMed:17005010, ECO:0000269|PubMed:17192411}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;TNFalpha;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.999
- rvis_EVS
- -2.29
- rvis_percentile_EVS
- 1.23
Haploinsufficiency Scores
- pHI
- 0.191
- hipred
- N
- hipred_score
- 0.314
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.743
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sec16a
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;endoplasmic reticulum organization;Golgi organization;substantia nigra development;protein exit from endoplasmic reticulum;response to endoplasmic reticulum stress;Golgi to plasma membrane CFTR protein transport;COPII vesicle coating;protein stabilization;positive regulation of protein exit from endoplasmic reticulum;protein localization to endoplasmic reticulum exit site;protein localization to plasma membrane
- Cellular component
- Golgi membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;cytosol;ER to Golgi transport vesicle membrane;organelle membrane;perinuclear region of cytoplasm;endoplasmic reticulum exit site
- Molecular function
- protein binding